These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8612768)

  • 21. Human monkeypox and smallpox viruses: genomic comparison.
    Shchelkunov SN; Totmenin AV; Babkin IV; Safronov PF; Ryazankina OI; Petrov NA; Gutorov VV; Uvarova EA; Mikheev MV; Sisler JR; Esposito JJ; Jahrling PB; Moss B; Sandakhchiev LS
    FEBS Lett; 2001 Nov; 509(1):66-70. PubMed ID: 11734207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for glycosphingolipid modification of the type 1 IFN receptor.
    Ghislain J; Lingwood CA; Fish EN
    J Immunol; 1994 Oct; 153(8):3655-63. PubMed ID: 7930586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallization of the complex of human IFN-gamma and the extracellular domain of the IFN-gamma receptor.
    Chène C; Fountoulakis M; Döbeli H; D'Arcy B; Winkler F; D'Arcy A
    Proteins; 1995 Dec; 23(4):591-4. PubMed ID: 8749856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alastrim smallpox variola minor virus genome DNA sequences.
    Shchelkunov SN; Totmenin AV; Loparev VN; Safronov PF; Gutorov VV; Chizhikov VE; Knight JC; Parsons JM; Massung RF; Esposito JJ
    Virology; 2000 Jan; 266(2):361-86. PubMed ID: 10639322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The virology of variola minor. Correlation of laboratory tests with the geographic distribution and human virulence of variola isolates.
    Dumbell KR; Huq F
    Am J Epidemiol; 1986 Mar; 123(3):403-15. PubMed ID: 3004200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of complete human IFN-gamma receptor and its extracellular domain in insect cells: purification and characterization of the recombinant proteins.
    Moosmayer D; Gerlach E; Böttinger H; Scheurich P; Pfizenmaier K
    Lymphokine Cytokine Res; 1994 Apr; 13(2):147-53. PubMed ID: 8061116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variola virus immune evasion proteins.
    Dunlop LR; Oehlberg KA; Reid JJ; Avci D; Rosengard AM
    Microbes Infect; 2003 Sep; 5(11):1049-56. PubMed ID: 12941397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A point mutation of human interferon gamma abolishes receptor recognition.
    Lunn CA; Fossetta J; Dalgarno D; Murgolo N; Windsor W; Zavodny PJ; Narula SK; Lundell D
    Protein Eng; 1992 Apr; 5(3):253-7. PubMed ID: 1409546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor.
    Soh J; Donnelly RJ; Kotenko S; Mariano TM; Cook JR; Wang N; Emanuel S; Schwartz B; Miki T; Pestka S
    Cell; 1994 Mar; 76(5):793-802. PubMed ID: 8124716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The myxoma virus-soluble interferon-gamma receptor homolog, M-T7, inhibits interferon-gamma in a species-specific manner.
    Mossman K; Upton C; McFadden G
    J Biol Chem; 1995 Feb; 270(7):3031-8. PubMed ID: 7852384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.
    Rosengard AM; Liu Y; Nie Z; Jimenez R
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8808-13. PubMed ID: 12034872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A bivalent immunoadhesin of the human interferon-gamma receptor is an effective inhibitor of IFN-gamma activity.
    Moosmayer D; Gerlach E; Hauff R; Becker P; Brocks B; Pfizenmaier K
    J Interferon Cytokine Res; 1995 Dec; 15(12):1111-5. PubMed ID: 8746794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction and properties of fusion proteins between human interferon-gamma and human tumour necrosis factors alpha and beta.
    Korobko VG; Davydov IV; Shingarova LN; Filippov SA; Esipov DS; Dobrynin VN
    Biomed Sci; 1991; 2(6):634-40. PubMed ID: 1668714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A point mutation that decreases the thermal stability of human interferon gamma.
    Lunn CA; Fossetta J; Murgolo N; Zavodny PJ; Lundell D; Narula SK
    Protein Eng; 1992 Apr; 5(3):249-52. PubMed ID: 1409545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12.
    Schijns VE; Wierda CM; van Hoeij M; Horzinek MC
    J Immunol; 1996 Jul; 157(2):815-21. PubMed ID: 8752933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stable conformation of an interferon-gamma receptor binding peptide in aqueous solution is required for interferon-gamma antagonist activity.
    Jarpe MA; Johnson HM
    J Interferon Res; 1993 Apr; 13(2):99-103. PubMed ID: 8509661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terminal region sequence variations in variola virus DNA.
    Massung RF; Loparev VN; Knight JC; Totmenin AV; Chizhikov VE; Parsons JM; Safronov PF; Gutorov VV; Shchelkunov SN; Esposito JJ
    Virology; 1996 Jul; 221(2):291-300. PubMed ID: 8661439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular cell biology of interferon-gamma and its receptor.
    Farrar MA; Schreiber RD
    Annu Rev Immunol; 1993; 11():571-611. PubMed ID: 8476573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virulence of variola viruses for suckling mice.
    Huq F; Dumbell KR
    Trans R Soc Trop Med Hyg; 2003; 97(1):97-9. PubMed ID: 12886813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homology model of human interferon-alpha 8 and its receptor complex.
    Seto MH; Harkins RN; Adler M; Whitlow M; Church WB; Croze E
    Protein Sci; 1995 Apr; 4(4):655-70. PubMed ID: 7613464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.